Intra-individual variability and longitudinal changes in glycaemic control in patients with type 1 diabetes mellitus

Diabetic Medicine

Volumn 17, Issue 6, 2000, Pages 451-456

  Jorde, Rolf ^a,b   Sundsfjord, J ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Diabetes mellitus; HbA(1c); Longitudinal study

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; DIABETES CONTROL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE;

EID: 0033942934     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00295.x     Document Type: Article

References (16)

1. 1 The Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetes retinopathy and albuminuria. N Engl J Med 1984; 311: 365-372.
2. 2 Lauritzen T, Larsen KF, Larsen HN, Deckert T. Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and nephropathy. Diabetes 1985 (Suppl. 3); 34:74-79.
3. 3 Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes mellitus. Lancet 1986; ii: 1300-1304.
4. 4 Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjoro T, Sandvik L, Aagenæs O. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta Endocrinol 1988; 117: 19-25.
5. 5 The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
6. 6 Thompson CJ, Gould C, Cummings JFR, Newton RW, Chalmers J. How have patients reacted to the implications of the DCCT? Diabetes Care 1996; 19: 876-879.
7. 1C in diabetes mellitus. N Engl J Med 1976; 295: 417-420.
8. 8 Ferrie CD, Sharpe TC, Price DA, Surtees RA. Seasonal variation in glycosylated haemoglobin. Arch Dis Child 1987; 62: 959-960.
9. 1C in adult diabetic patients. Diab Care 1997; 20: 234.
10. 10 Palta M, Shen G, Allen C, Klein R, D'Alessio D. Longitudinal patterns of glycemic control and diabetes care from diagnosis in a population-based cohort with Type I diabetes. Am J Epidemiol 1996; 144: 954-961.
11. 11 Klein R, Moss SE, Klein BEK. Change in glycemia in a four-year interval in younger-onset insulin-dependent diabetes. Ann Epidemiol 1992; 2: 283-294.
12. 12 Singh BM, McNamara C, Wise PH. High variability of glycated hemoglobin concentrations in patients with IDDM followed over 9 years. What is the best index of long-term glycemic control? Diabetes Care 1997; 20: 306-308.
13. 13 Bott U, Jorgens V, Grüsser M, Bender R, Mühlhauser I, Berger M. Predictors of glycaemic control in Type I diabetic patients after participation in an intensified treatment and teaching programme. Diabetic Med 1994; 11: 362-371.
14. 14 Goldstein D, Little R, Wiedmeyer H, England J, Rohlfing C, Madsen R. Glycated hemoglobin (GHB) at diagnosis (Dx) is related to the 5th year GHB value in children with Type I diabetes mellitus (IDDM). Diabetes 1991; 40: 482A.
15. 15 Nathan DM, McKitrick C, Larkin M, Schaffran R, Singer DE. Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med 1996; 100: 157-163.
16. 16 Allen C, Zaccaro DJ, Palta M, Klein R, Duck SC, D'Alessio DJ. Glycemic control in early IDDM. Diabetes Care 1992; 15: 980-987.